RESMED, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 216.3 USD | +17.93% |
|
+21.39% | +26.21% |
| 05:37pm | KeyBanc Adjusts Price Target on ResMed to $238 From $227 | MT |
| 05:04pm | ResMed's Fiscal Q3 Non-GAAP Earnings, Revenue Increase; Shares Up Over 17% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows:
- medical devices (50.4%);
- masks (37.9%);
- software as a service (11.7%).
At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia.
The United States accounts for 61.4% of net sales.
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
183.4
USD
Average target price
208.6
USD
Spread / Average Target
+13.72%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +26.21% | 26.94B | |
| +7.95% | 218B | |
| +6.93% | 182B | |
| +11.46% | 132B | |
| +26.95% | 108B | |
| +13.57% | 52.98B | |
| -0.62% | 47.59B | |
| -0.73% | 39.96B | |
| +11.06% | 39.22B | |
| -11.45% | 19.28B |
- Stock Market
- Equities
- RMD Stock
- News ResMed, Inc.
- Insider Sell: Resmed
